Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis. Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors Int J Clin Oncol. Pre-operative Risk Stratification for Cancer-specific Survival in Patients with Renal Cell Carcinoma with Venous Involvement Who Underwent Nephrectomy. Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. Role of C-reactive protein as a biomarker for renal cell carcinoma. Role of C-reactive protein in urological cancers: A useful biomarker for predicting outcomes. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Prognostic Impact of C-reactive Protein for Determining Overall Survival of Patients With Castration-resistant Prostate Cancer Treated With Docetaxel. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically. C-reactive protein predicts prognosis in patients with muscle-invasive bladder cancer treated with chemoradiotherapy. Impact of C-reactive protein kinetics on survival of patients with metastatic renal cell carcinoma. External validation of TNM-C score in three community hospital cohorts for clear cell renal cell carcinoma. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. Diagnostic contribution of C-reactive protein kinetics for gastric metastasis from renal cell carcinoma. C-reactive protein as a biomarker for urological cancers.。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。
。